Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Sanofi
|
| gptkbp:acquisitionYear |
2011
|
| gptkbp:focusArea |
oncology
multiple sclerosis rare diseases |
| gptkbp:foundedBy |
gptkb:Sheridan_Snyder
|
| gptkbp:foundedYear |
1981
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Genzyme (2011)
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:keyPerson |
gptkb:Henri_Termeer
|
| gptkbp:notableProduct |
gptkb:Aldurazyme
gptkb:Cerezyme gptkb:Fabrazyme gptkb:Myozyme |
| gptkbp:numberOfEmployees |
~11,000 (2011)
|
| gptkbp:parentCompany |
gptkb:Sanofi
|
| gptkbp:status |
subsidiary of Sanofi (after 2011)
|
| gptkbp:stockSymbol |
gptkb:GENZ
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:bfsParent |
gptkb:Sanofi
|
| gptkbp:bfsLayer |
5
|